JeanMarie Guenot is the current president of Amphivena Therapeutics, Inc. The business administrator with extensive experience in biotechnology and pharmaceuticals has worked for various companies in the public and private sector. Dr. Jeanmarie Guenot studied at the University of Pennsylvania where she earned her MBA. She is also an alumnus of the University of California where she pursed her PhD. JeanMarie has always been interested in building and reconstructing companies. Over the years, she has worked in areas related to therapeutics. Her recent work was on ophthalmology at https://www.linkedin.com/in/jeanmarie-guenot-4a140617. Guenot has worked for SKS Ocular as a key operating and business officer.
Dr. Guenot was Hoffmann-La Roche’s business advisor in Shanghai and Basel from 2008 to 2009. Previously, she served at the vice president of corporate & business development and PDL BioPharma. In this corporation, she was responsible for supervising licensing, enhancing alliance management and engaging in acquisition and mergers for the company’s commercial portfolios on takeda.com
. She has also participated in the development of cancer drugs where she was a negotiator and leader of the Biogen Idec-PDL 50:50. In 2005, she received the Innovative Award of Bio-Partnering from BioBusiness Network. In 2006, the Licensing Executive Society awarded her with the Deal of Distinction.
In 2008, she transferred the rights of product to Ophthotech Company. She also played a key role in the sale of manufacturing and commercial businesses of PDL. JeanMarie was a member of the Portfolio Management Committee and the Executive Team of PDL. She has vast experience in the fields of oncology, cardiovascular, neurology, ophthalmic and autoimmune diseases.
Dr. Guenot started her career in business at Atlas Venture where she serves as the manager in charge of capital investment on guenotllc.com. She has also served on the boards of different companies. Moreover, she rendered her services at Hoffmann-La Roche as a principal scientist in preclinical R&D. It is here where JeanMarie started her scientific career. As a scientist, she discovered and developed drugs for inflammation, oncology, metabolic and autoimmune diseases.